PURPOSE: Five genetic variants along chromosomes 8q24 and 17q have a cumulative association with prostate cancer risk. Our research group previously reported an association between these variants and clinicopathological characteristics. More recently 4 additional prostate cancer susceptibility variants were identified on chromosomes 2p15, 10q11, 11q13 and Xp11. We performed cumulative risk assessment incorporating all 9 genetic variants and determined the relationship of the new variants to clinicopathological tumor features. MATERIALS AND METHODS: The genotype of 9 variants was determined in 687 men of European ancestry who underwent radical prostatectomy from 2002 to 2008 and in 777 healthy volunteer controls. We compared the incidence of these variants in prostate cancer cases and controls, and assessed their cumulative risk. We also determined the relationship of carrier status for the 4 new variants and clinicopathological tumor features. RESULTS: Prostate cancer cases had an increased incidence of all 9 risk variants compared to controls. A cumulative model including the 9 single nucleotide polymorphisms provided greater prostate cancer risk stratification than a model restricted to the original 5 single nucleotide polymorphisms described. Specifically men with 6 or more variants were at greater than 6-fold increased risk for prostate cancer. Although 2p15 and 11q13 carriers were more likely to have aggressive features, other clinicopathological features were similar in carriers and noncarriers. CONCLUSIONS: Genetic variants located in 9 regions have a cumulative association with prostate cancer risk. Identification of an increasing number of single nucleotide polymorphisms may provide greater understanding of their combined relationship with CaP risk and disease aggressiveness. Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
PURPOSE: Five genetic variants along chromosomes 8q24 and 17q have a cumulative association with prostate cancer risk. Our research group previously reported an association between these variants and clinicopathological characteristics. More recently 4 additional prostate cancer susceptibility variants were identified on chromosomes 2p15, 10q11, 11q13 and Xp11. We performed cumulative risk assessment incorporating all 9 genetic variants and determined the relationship of the new variants to clinicopathological tumor features. MATERIALS AND METHODS: The genotype of 9 variants was determined in 687 men of European ancestry who underwent radical prostatectomy from 2002 to 2008 and in 777 healthy volunteer controls. We compared the incidence of these variants in prostate cancer cases and controls, and assessed their cumulative risk. We also determined the relationship of carrier status for the 4 new variants and clinicopathological tumor features. RESULTS:Prostate cancer cases had an increased incidence of all 9 risk variants compared to controls. A cumulative model including the 9 single nucleotide polymorphisms provided greater prostate cancer risk stratification than a model restricted to the original 5 single nucleotide polymorphisms described. Specifically men with 6 or more variants were at greater than 6-fold increased risk for prostate cancer. Although 2p15 and 11q13 carriers were more likely to have aggressive features, other clinicopathological features were similar in carriers and noncarriers. CONCLUSIONS: Genetic variants located in 9 regions have a cumulative association with prostate cancer risk. Identification of an increasing number of single nucleotide polymorphisms may provide greater understanding of their combined relationship with CaP risk and disease aggressiveness. Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Authors: Claudia A Salinas; Joseph S Koopmeiners; Erika M Kwon; Liesel FitzGerald; Daniel W Lin; Elaine A Ostrander; Ziding Feng; Janet L Stanford Journal: Prostate Date: 2009-03-01 Impact factor: 4.104
Authors: Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Thorarinn Blondal; Arnaldur Gylfason; Bjarni A Agnarsson; Kristrun R Benediktsdottir; Droplaug N Magnusdottir; Gudbjorg Orlygsdottir; Margret Jakobsdottir; Simon N Stacey; Asgeir Sigurdsson; Tiina Wahlfors; Teuvo Tammela; Joan P Breyer; Kate M McReynolds; Kevin M Bradley; Berta Saez; Javier Godino; Sebastian Navarrete; Fernando Fuertes; Laura Murillo; Eduardo Polo; Katja K Aben; Inge M van Oort; Brian K Suarez; Brian T Helfand; Donghui Kan; Carlo Zanon; Michael L Frigge; Kristleifur Kristjansson; Jeffrey R Gulcher; Gudmundur V Einarsson; Eirikur Jonsson; William J Catalona; Jose I Mayordomo; Lambertus A Kiemeney; Jeffrey R Smith; Johanna Schleutker; Rosa B Barkardottir; Augustine Kong; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson Journal: Nat Genet Date: 2009-09-20 Impact factor: 38.330
Authors: Hong Lou; Meredith Yeager; Hongchuan Li; Jesus Gonzalez Bosquet; Richard B Hayes; Nick Orr; Kai Yu; Amy Hutchinson; Kevin B Jacobs; Peter Kraft; Sholom Wacholder; Nilanjan Chatterjee; Heather Spencer Feigelson; Michael J Thun; W Ryan Diver; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Jing Ma; J Michael Gaziano; Meir Stampfer; Fredrick R Schumacher; Edward Giovannucci; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; E David Crawford; Stephen K Anderson; Margaret Tucker; Robert N Hoover; Joseph F Fraumeni; Gilles Thomas; David J Hunter; Michael Dean; Stephen J Chanock Journal: Proc Natl Acad Sci U S A Date: 2009-04-21 Impact factor: 11.205
Authors: Fredrik E Wiklund; Hans-Olov Adami; Sigun L Zheng; Pär Stattin; William B Isaacs; Henrik Grönberg; Jianfeng Xu Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-05 Impact factor: 4.254
Authors: Fang-Chi Hsu; Jielin Sun; Fredrik Wiklund; Sarah D Isaacs; Kathleen E Wiley; Lina D Purcell; Zhengrong Gao; Pär Stattin; Yi Zhu; Seong-Tae Kim; Zheng Zhang; Wennuan Liu; Bao-Li Chang; Patrick C Walsh; David Duggan; John D Carpten; William B Isaacs; Henrik Grönberg; Jianfeng Xu; S Lilly Zheng Journal: Cancer Res Date: 2009-03-24 Impact factor: 12.701
Authors: A Karim Kader; Jielin Sun; Sarah D Isaacs; Kathleen E Wiley; Guifang Yan; Seong-Tae Kim; Helen Fedor; Angelo M DeMarzo; Jonathan I Epstein; Patrick C Walsh; Alan W Partin; Bruce Trock; S Lilly Zheng; Jianfeng Xu; William Isaacs Journal: Prostate Date: 2009-08-01 Impact factor: 4.104
Authors: S Lilly Zheng; Victoria L Stevens; Fredrik Wiklund; Sarah D Isaacs; Jielin Sun; Shelly Smith; Kristen Pruett; Kathleen E Wiley; Seong-Tae Kim; Yi Zhu; Zheng Zhang; Fang-Chi Hsu; Aubrey R Turner; Jan-Erik Johansson; Wennuan Liu; Jin Woo Kim; Bao-Li Chang; David Duggan; John Carpten; Carmen Rodriguez; William Isaacs; Henrik Grönberg; Jianfeng Xu Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-06 Impact factor: 4.254
Authors: Bao-Li Chang; Scott D Cramer; Fredrik Wiklund; Sarah D Isaacs; Victoria L Stevens; Jielin Sun; Shelly Smith; Kristen Pruett; Lina M Romero; Kathleen E Wiley; Seong-Tae Kim; Yi Zhu; Zheng Zhang; Fang-Chi Hsu; Aubrey R Turner; Jan Adolfsson; Wennuan Liu; Jin Woo Kim; David Duggan; John Carpten; S Lilly Zheng; Carmen Rodriguez; William B Isaacs; Henrik Grönberg; Jianfeng Xu Journal: Hum Mol Genet Date: 2009-01-19 Impact factor: 6.150
Authors: Barry B McGuire; Brian T Helfand; Shilajit Kundu; Qiaoyan Hu; Jessica A Banks; Phillip Cooper; William J Catalona Journal: BJU Int Date: 2011-11-11 Impact factor: 5.588
Authors: Sarah M Troutman; Tristan M Sissung; Cheryl D Cropp; David J Venzon; Shawn D Spencer; Bamidele A Adesunloye; Xuan Huang; Fatima H Karzai; Douglas K Price; William D Figg Journal: Oncologist Date: 2012-03-01
Authors: Brian T Helfand; Stacy Loeb; Qiaoyan Hu; Phillip R Cooper; Kimberly A Roehl; Barry B McGuire; Nikola A Baumann; William J Catalona Journal: J Urol Date: 2013-02-27 Impact factor: 7.450
Authors: Daniel Reinhardt; Brian T Helfand; Phillip R Cooper; Kimberly A Roehl; William J Catalona; Stacy Loeb Journal: J Urol Date: 2013-12-15 Impact factor: 7.450
Authors: Julian Little; Brenda Wilson; Ron Carter; Kate Walker; Pasqualina Santaguida; Eva Tomiak; Joseph Beyene; Muhammad Usman Ali; Parminder Raina Journal: Genet Med Date: 2015-10-01 Impact factor: 8.822
Authors: James T Kearns; Brittany Lapin; Edward Wang; Kimberly A Roehl; Phillip Cooper; William J Catalona; Brian T Helfand Journal: Eur Urol Date: 2015-09-26 Impact factor: 20.096